CALVIRI

Calviris mission is to provide affordable products worldwide that will end deaths from cancer. We are a fully integrated healthcare company developing a broad spectrum of vaccines and companion diagnostics that prevent and treat cancer for those either at risk or diagnosed. We focus on using frameshift neoantigens derived from errors in RNA processing to provide pioneering products against cancer. The company is a spin out of the Biodesign Institute, Arizona State University, located in Phoenix, AZ. We have the largest dog vaccine trial in the world underway at three premier veterinary universities. The five-year trial will assess the performance...

Vaccines,diagnostics,oncology,therapeutic,prevention,prophylactic,neoantigens,veterinary,healthcare,startup,stephen albert johnston,peptides,arrays,calviri,biotech,science,research,dog trial,cancervaccines,cancer vaccines,early cancer detection,ici diagnostic,clinical trials,let's end cancer,and end cancer

Calviri operates in the Biotechnology industry.

Calviri's revenue is 11m - 100m

Calviri has 11 - 50 employees.